Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-08-28
2007-08-28
Graser, Jennifer (Department: 1645)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S252300, C435S069300, C435S071100, C435S243000, C536S023100, C536S023700, C536S024100, C536S024200
Reexamination Certificate
active
10324143
ABSTRACT:
The present invention relates to polypeptides ofStreptococcus pneumoniaewhich may be used for prophylaxis, diagnostic and/or therapy purposes.
REFERENCES:
patent: 6582706 (2003-06-01), Johnson et al.
patent: 6699703 (2004-03-01), Doucette-Stamm et al.
patent: 6800744 (2004-10-01), Doucette-Stamm et al.
patent: 2003/0077293 (2003-04-01), Hamel et al.
patent: 2004/0081662 (2004-04-01), Hermand et al.
patent: WO98/18930 (1998-05-01), None
patent: WO98/18931 (1998-05-01), None
patent: WO99/15675 (1999-04-01), None
patent: WO 00/06737 (2000-02-01), None
patent: WO 00/06738 (2000-02-01), None
patent: WO 00/17370 (2000-03-01), None
patent: WO 00/37105 (2000-06-01), None
patent: WO00/37105 (2000-06-01), None
patent: WO 00/39299 (2000-07-01), None
patent: WO 00/76540 (2000-12-01), None
patent: WO 01/14421 (2001-03-01), None
patent: WO01/98334 (2001-12-01), None
patent: WO02/077021 (2002-10-01), None
patent: WO2004/092209 (2004-10-01), None
Mikayama et al. (Nov. 1993. Proc.Natl.Acad.Sci. USA, vol. 90 : 10056-10060).
Rudinger et al. (Jun. 1976. Peptide Hormones. Biol.Council. pp. 5-7).
Hamel et al (WO 20039229 corresponding to Gencore Accession No. AAA65737).
Adamou et al (Infect. Immun. Feb. 2001, 69(2): 949-958).
Milenen Hernandez et al., “Antigenicity of Chimeric Synthetic Peptides Based on HTLV-1 Antigens and the Impact of Eptiope Orientation.” Biochemical and Biophysical Research Communication. vol. 276. No. 3, pp. 1085-1088.
Charalambos Partidos et al., “The Influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies Induced by chimeric peptides.” Molecular Immunology Unit, Department of Clinical Sciences, London School of Hygiene and Tropical Medicine, London. Eur. J. Immunol 1992, 22: pp. 2675-2680.
Oishi Y. et al., “The effect of the amino acid spacers on the antigenicity of dimeric peptide-inducing cross reacting antibodies to a cell surface protein antigen of Streptococcus mutans.” Oral Microbiol Immunol 2001: 16: pp. 40-44.
Kurstak Edward, “Editorial Recent progress in vaccines development and new trends in immunization.” Vaccine 19 (2001) pp. 2198-2200.
Briles D.E. et al, Immunization of Humans with Recombinant Pneumococcal Surface Protein A (rPsspA) Elicits Antibodies that Passively Protect Mice from Fatal Infection withStreptococcus pneumoniaebearing Heterologous PspA J Infectious Disease 182 (Dec. 2000) 1694-1701.
Briles, D.E. et al, Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA is Highly Protective against Nasopharyngeal Carriage ofStreptococcus pneumoniaeInfection & Immunity vol. 68 No. 2 (Feb. 2000) p. 796-800.
Gregor Z. et al, Detection of 23 Immuogenic Pneumococcal Proteins Using Convalescent-Phase Serum Infection & Immunity vol. 68 No. 6 (Jun. 2000) p. 3740-43 (exact publication date not available).
“Comparison of D1 (Seq ID Nos. 56 and 66) with BVH-11 Seq ID Nos. 7 and 8 of the present invention”.
Boslego et al. “Vaccines And Immuntherapy” Pergamon Press, 1991, Chapter 17, pp. 211-223.
Ellis, et al. “New Technologies for Making Vaccines,” WB Sanders Co., 1988, Chapter 29, pp. 568-575.
Spellerberg, et al., “Lmb, a Protein with Similarities to the Lral Adhesin Family, Mediates Attachment ofStreptococcus agalactiaeto Human Laminin”, Infection and Immunity, Feb. 1999, p. 871-878.
Adamou, et al., “Identification and Characterization of a Novel Family of Pneumococcal Proteins That Are Protective Against Sepsis”, Infection and Immunity, Feb. 2001, p. 949-958.
Wizemann, et al., “Use of a Whole Genome Approach to Identify Vaccine Molecules Affording Protection AgainstStreptococcus pneumoniaeInfection”, Infection and Immunity, Mar. 2001, p. 1593-1598.
Zhang, et al., “Recombinant PhpA Protein, a Unique Histidine Motif-Containing Protein fromStreptococcus pneumoniae, Protects Mice against Intranasal Pneumococcal Challenge”, Infection and Immunity, Jun. 2001, p. 3827-3836.
U.S. Appl. No. 09/471,255, filed Dec. 23, 1999, Hamel et al.
Orihuela, et al., “Organ-specific models ofStreptococcus pneumoniaeDisease,” Scandinavian Journal of Infectious Diseases, vol. 35, No. 9, 2003, p. 647-652.
Whittam, et al. “Inference from whole-genome sequences of bacterial pathogens,” Current Opinion in Genetics and Development, Dec. 2002, vol. 12, No. 6, pp. 719-725.
Sa-Leao, et al., Abstracts of the General Meeting of the American Society for Microbiology, May 20-24, 2001.
Creighton, Thomas E., in his book, “Proteins: Structures and Molecular Principles,” 1984, pp. 314-315.
Creighton, Thomas E., in his book “Protein Structure: A Practical Approach,” 1989: pp. 184-186.
Nosoh, et al. in “Protein Stability and Stabilization through Protein Engineering,” 1991, pp. 197-217.
Oli, et al., “Redirecting the Humoral Immune Response against Streptococcus mutans Antigen P1 with Monoclonal Antibodies,” Infection and Immunity, Dec. 2004, p. 6951-6960.
Swildens, et al., “Intestinal translocation of Streptococcus suis type 2 EF+in pigs,” Veterinary Microbiology 103, 2004, pp. 29-33.
Bolton, et al., “Use of the surface proteins GapC and Mig ofStreptococcus dysgalactiaeas potential protective antigens against bovine mastitis,” Can J. Microbiol., Jun. 2004, 50(6):423-32 (Abstract only).
Okamoto, et al., “Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection,” Vaccine 22 (2004, pp. 2887-2893.
Blais Normand
Brodeur Bernard R.
Charland Nathalie
Hamel Josee
Labbe Steve
Graser Jennifer
ID Biomedical Corporation
Seed IP Law Group PLLC
LandOfFree
Streptococcus antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Streptococcus antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Streptococcus antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3898795